Vericel Corp (VCEL) Market Overview
- Current Trading Price – USD 42.97 per share on major exchanges.
- 24‑Hour Trading Activity – The stock closed up 0.89 % during the 24‑hour period ending 02:08 AM Central Europe time on Friday, 23 October 2026.
- Trading Volume – USD 17.7 million of Vericel shares were exchanged in the last 24 hours.
- Shares Outstanding – 51.3 million shares.
- Market Capitalisation – USD 2.1 billion.
- Historical Performance – Since the end of September, Vericel has gained 1.79 %.
- Technical Indicators – Simple moving average (200 days) is USD 38.52.
- 52‑Week Range – Highest price: USD 49.32 (30 July 2026); lowest price: USD 28.95 (27 March 2026).
Performance of Related Companies in the Past 24 Hours
| Symbol | Company | 24‑Hour Change | Current Price (USD) | Market Capitalisation (USD) | P/E Ratio |
|---|---|---|---|---|---|
| KALU | Kaiser Aluminum | +0.92 % | 114.99 | 2.5 bn | 11.31 |
| PGEN | Precigen | –3.37 % | 6.39 | 2.5 bn | — |
| IOSP | Innospec | +0.48 % | 98.67 | 2.4 bn | 20.32 |
| DXC | Dxc | +5.26 % | 16.08 | 2.5 bn | 20.62 |
| LCLN | Lincoln | –0.58 % | 24.58 | 2.5 bn | 5.83 |
About Vericel Corp
Vericel Corp is a biotechnology firm headquartered in Cambridge, Massachusetts, USA. The company focuses on the development of autologous stem/progenitor cell products for tissue repair and regeneration. Its proprietary Tissue Repair Cell (TRC) adult stem cell technology enables the production of bone marrow stem and progenitor cells derived from a patient’s own cells. These products aim to advance regenerative medicine and tissue engineering applications.
